Cardiomo Care
Generated 5/10/2026
Executive Summary
Cardiomo Care is a San Francisco-based digital health company developing an AI-powered remote cardiac monitoring platform that leverages wearable sensors and cloud-based analytics to provide continuous, real-time cardiovascular insights. Founded in 2019, the company addresses a critical need in early detection and management of cardiac conditions outside traditional clinical settings, potentially reducing hospitalizations and improving outcomes. Its technology combines machine learning algorithms with lightweight wearables that can be worn by patients at home, transmitting data directly to clinicians for remote intervention. This approach aligns with the broader shift toward value-based care and telehealth, particularly for chronic cardiovascular diseases which affect millions in the US alone.
Upcoming Catalysts (preview)
- Q3 2026FDA 510(k) clearance for next-generation monitoring device60% success
- Q4 2026Strategic partnership with a major health system for pilot deployment50% success
- Q1 2027Series A funding round led by healthcare-focused VC70% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)